Assignee
SIRIGEN II LTD
GB·21 granted patents·2 pending applications·212 citations·filing 2016–2025
Top patents by PatentIndex Score
23 records- 0199US11639937B2Fluorescent methods and materials for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted May 2, 2023·5 cites·7 claims
- 0298US12345713B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Jul 1, 2025·3 cites·28 claims
- 0398US11209438B2Fluorescent methods and materials for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2019·Granted Dec 28, 2021·9 cites·19 claims
- 0498US10962546B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2020·Granted Mar 30, 2021·17 cites·20 claims
- 0598US10955417B2Reagents for direct biomarker signal amplificationSIRIGEN II LTD·Filed 2020·Granted Mar 23, 2021·20 cites·20 claims
- 0698US10641775B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2019·Granted May 5, 2020·17 cites·20 claims
- 0798US10481161B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2019·Granted Nov 19, 2019·17 cites·23 claims
- 0898US10458989B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2019·Granted Oct 29, 2019·34 cites·20 claims
- 0998US10365285B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2017·Granted Jul 30, 2019·19 cites·20 claims
- 1098US10302648B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2017·Granted May 28, 2019·30 cites·20 claims
- 1198US10094838B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2016·Granted Oct 9, 2018·37 cites·33 claims
- 1296US11333666B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2019·Granted May 17, 2022·4 cites·9 claims
- 1393US12111321B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2024·Granted Oct 8, 2024·0 cites·25 claims
- 1491US2025362301A1Fluorescent Methods and Materials for Directed Biomarker Signal AmplificationSIRIGEN II LTD·Filed 2025·Application pending·0 cites
- 1589US12241898B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2023·Granted Mar 4, 2025·0 cites·30 claims
- 1689US12235274B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2023·Granted Feb 25, 2025·0 cites·30 claims
- 1789US12153050B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Nov 26, 2024·0 cites·27 claims
- 1889US2026063640A1Reagents for Directed Biomarker Signal AmplificationSIRIGEN II LTD·Filed 2025·Application pending·0 cites
- 1988US12366578B2Fluorescent methods and materials for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Jul 22, 2025·0 cites·18 claims
- 2086US12366577B2Fluorescent methods and materials for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2021·Granted Jul 22, 2025·0 cites·14 claims
- 2185US12253525B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Mar 18, 2025·0 cites·25 claims
- 2285US11899018B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Feb 13, 2024·0 cites·32 claims
- 2385US11874278B2Reagents for directed biomarker signal amplificationSIRIGEN II LTD·Filed 2022·Granted Jan 16, 2024·0 cites·32 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →